Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab as a ...
Those with AI skills are said to make more, but how much more? Also, how have our actual experts been using AI in their own ...
The market regulator has proposed a uniform 30-day delay in using price data for investor education to remove regulatory ...
Variable names are alphanumeric but must start with a letter. The length of a variable name is limited to thirty-two characters for non-SAS data set variables Model variables are declared by VAR, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback